OptMed
develops and commercializes biocompatible polymer and genitourinary therapeutics... Read moreOptMed
develops and commercializes biocompatible polymer and genitourinary therapeutics... Read more
News
Oct 16, 2024
StreetInsider
Press Release: OptMed : OptMed Inc. receives clearance from the U.S. Food & Drug Administration (FDA) for its 510(k) TearRepair Liquid Skin Protectant
Jun 13, 2023
Proactive Investors
OptMed: OptMed spikes $23 million IPO
Jun 20, 2022
Seeking Alpha
OptMed: OptMed Begins $24 Million U.S. IPO Effort
Jun 16, 2022
Seeking Alpha
OptMed: Surgical adhesives developer OptMed files for $23M IPO
Jan 12, 2016
BioSpace
OptMed: <b>OptMed</b> Wins FDA Marketing Approval For Its Topical Surgical Skin Adhesive, BondEase
OptMed Competitors
1
2
3
4
5
6
7
8
9
10